Cite
MLA Citation
Ronghao Wang et al.. “ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L.” Cancer letters, vol. 379, no. 1, 2016, pp. 154–160. http://access.bl.uk/ark:/81055/vdc_100034056397.0x00004c